Could cause temporary or reversible harm; serious harm is unlikely.
Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.
| Brand name | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE |
| Generic name | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE |
| Active ingredient(s) | AMPHETAMINE ASPARTATE MONOHYDRATE, AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, DEXTROAMPHETAMINE SULFATE |
| Distributed by / for | Aurobindo Pharma USA Inc., Dayton, NJ 08810 |
| NDC | 13107-073-01 |
| Full product label | Dextroamphetamine Sacharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Mixed Salts of a single Entity Amphetamine Product), 20mg, 100-count bottle, RX Only, Distributed by: Aurobindo Pharma USA Inc., Dayton, NJ 08810, NDC 13107-073-01 |
| Recalling firm | Aurobindo Pharma USA Inc. |
| Distribution | Nationwide in the US |
| Quantity | 11,129 100-count bottles |
| Recall initiated | 2019-09-19 |
| Report date | 2019-10-23 |
| Recall completed | 2023-04-04 |
| Recall number | D-0143-2020 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | East Windsor NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗